On Oct. 21, 2025, the Oregon Department of Agriculture has warned that as wild birds begin to migrate…
On Oct. 21, 2025, in the latest bid to plug gaps in the federal government’s public health infrastructure,…
On Oct. 20, 2025, the Millennium Seed Bank at the Royal Botanic Gardens Kew, located deep underground beneath…
On Oct. 20, 2025, Merck announced the start of construction for a $3 billion, 400,000-square-foot pharmaceutical manufacturing facility…
On Oct. 20, 2025, Glaukos announced today the U.S. Food and Drug Administration (FDA) approved its Epioxa™ HD…
On Oct. 20, 2025, The Jackson Laboratory (JAX), a global leader in genetics and genomic medicine, announced it…
On Oct. 20, 2025, ACG, the world’s most integrated provider of solid-dosage solutions, announced a $200 million phased…
On Oct. 18, 2025, GRAIL announced that positive performance and safety results from its registrational PATHFINDER 2 study…
On Oct. 18, 2025, the Swiss Pharma giant F Hoffmann La Roche (Roche) suffered a setback as the…
On Oct. 17, 2025, Chinese biotech Hansoh Pharma said it had signed a license agreement worth up to…
On Oct. 17, 2025, Boston Scientific announced it has entered into a definitive agreement to acquire Nalu Medical,…
On Oct. 17, 2025, Novo Nordisk announced that the US Food and Drug Administration (FDA) has approved Rybelsus®, the only oral GLP-1…
On Oct. 16, 2025, the Food and Drug Administration (FDA) announced the first round of experimental drugs that…
On Oct. 15, 2025, mRNA COVID-19 vaccination in the first trimester of pregnancy isn’t tied to an elevated…
On Oct. 15, 2025, Broad Clinical Labs, in collaboration with Roche Sequencing Solutions and Boston Children’s Hospital, announced…
On Oct. 15, 2025, Danish drugmaker Novo Nordisk and Omeros announced they have signed a licensing deal worth…
On Oct. 14, 2025, researchers Texas A&M University School of Engineering Medicine (EnMed) announced development of a portable…
On Oct. 14, 2025, Japan’s health authorities have declared an influenza epidemic, with thousands of people infected with…
On Oct. 14, 2025, researchers at Cincinnati Children’s in collaboration with Roche, have developed a next-generation human liver…
On Oct. 13, 2025, researchers from Texas A&M University announced they have identified two estrogens, estradiol and estriol,…
On Oct. 13, 2025, the World Health Organization (WHO) reported that one in six laboratory-confirmed bacterial infections causing…
On Oct. 13, 2025, the U.S. Food and Drug Administration (FDA) announces it has cleared the Elecsys pTau181…
On Oct. 13, 2025, University of Cambridge scientists announced they have used human stem cells to create three-dimensional…
On Oct. 10, 2025, Bristol Myers Squibb (BMS) and Orbital Therapeutics announced a definitive agreement under which BMS…
On Oct. 10, 2025, AstraZeneca announced a historic agreement with President Donald J. Trump’s administration to lower the…
On Oct. 10, 2025, Ypsomed announced it will establish its first manufacturing facility in the United States. The…
On Oct. 9, 2025, Boehringer Ingelheim’s JASCAYD® (nerandomilast) tablets has been approved by the U.S. Food and Drug…
On Oct. 9, 2025, Celltrion announced announced that the U.S. Food and Drug Administration (FDA) has approved EYDENZELT® (aflibercept-boav), biosimilar…
On Oct. 9, 2025, Beicheng Sun at Anhui Medical University in China and his colleagues have reported the…
On Oct. 8, 2025, The Royal Swedish Academy of Sciences has decided to award the Nobel Prize in…